Targeted AAV gene therapy for vertical supranuclear gaze palsy and dysphagia
Awardee: Charles Vite
Institution: University of Pennsylvania
Award Amount: $53,500
Funding Period: January 1, 2016 - December 31, 2016
Previous
Previous
Natural history study and biomarker development in the large animal model of mucolipidosis II
Next
Next